TP53 and cancer: Following this, the Asian Cancer Research Group conducted a study built on TCGA molecular classification and co-relate it with clinical outcomes and identified four distinct subtypes, including MSI-High, Microsatellite stability (MSS)/epithelial-mesenchymal transition, MSS/TP53 intact and MSS/TP53 loss [22].